Januvia, Janumet, Byetta, Victoza
Januvia, Janumet, Byetta, and Victoza are a set of chemically-related but distinct drugs marketed to lower blood glucose levels in Type 2 diabetics. Januvia is a once-daily pill using the active ingredient sitagliptin; Janumet combines the active ingredient from Januvia with an additional ingredient in a single pill; Byetta and Victoza are injection drugs using exenatide. While the drugs differ in intake method and chemical makeup, they all work to lower blood glucose and control the activities of the liver and pancreas. Throughout 2009, the Food and Drug Administration (FDA) notified medical professionals that these drugs could be dangerous after Januvia and Byetta users reported severe cases of pancreatitis; the FDA went as far as authorizing a Risk Evaluation and Mitigation Strategy for Byetta, meaning a full-scale investigation into its ties to pancreatic cancers was commissioned. Lawsuits launched against the manufacturers of these drugs (Merck, Amylin, Eli Lilly, Bristol-Myers Squibb, and Novo Nordisk A/S) allege that the companies knew their Type 2 diabetes medicines put patients at risk for pancreatic illness but did not alert consumers or medical professionals of the possible dangers. If you or someone you love took Januvia, Janumet, Byetta, or Victoza and suffered from pancreatic cancer, pancreatitis, or other illnesses affecting the pancreas, you may be entitled to significant legal benefits to help cover the costs of treatment and other expenses associated with your condition.
Grimes Teich Anderson LLP only works to protect the interests of injured consumers, defending them against the hazards presented by gross corporate negligence. Grimes Teich Anderson often associates national co-counsel with proven experience in these matters. We will serve as your local contact and counsel and work with national counsel to recover fair compensation. Trust this team to protect you and your interests in going after the benefits to which you are entitled for your Januvia, Janumet, Byetta, or Victoza-related pancreatic disease.
You should never expect business-interested corporate leaders to stand up for your rights as consumers, as they answer only to their shareholders and bottom lines. Do not expect the makers of Januvia, Janumet, Byetta, or Victoza to offer you any money, and if they do be prepared for a lowball offer that fails to cover the expenses associated with your pancreatic cancer, pancreatitis, or other disease of the pancreas. You should also understand that if you go it alone in filing your claim you may undervalue the benefits package to which you have a legal right or wait too long to take legal action in your own interests, negating some or all of your legal rights and possibly thousands of dollars. If you took any of these Type II diabetes drugs and then suffered from any of a number of life-threatening diseases of the pancreas, do not try your claim without the help of a Grimes Teich Anderson attorney by your side. If you choose to go it alone it could cost you more than just your peace of mind.FREE CASE EVALUATION
If you or a loved one took Januvia, Janumet, Byetta, or Victoza as part of a Type II diabetes regulating regimen and subsequently suffered pancreatic cancer, pancreatitis, or other diseases affecting the pancreas, please call 800.533.6845 to request a free consultation with a Grimes Teich Anderson personal injury attorney. You may also fill out an online case evaluation form if this is more convenient for you.
Grimes Teich Anderson LLP has law offices located in Spartanburg, Greenville, and Gaffney, South Carolina and Asheville, Waynesville, Rutherfordton, Spruce Pine, and Franklin, North Carolina.